Terms: = Head and neck cancer AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck AND Treatment
9 results:
1. Differentially Expressed Genes Involved in Primary Resistance to Immunotherapy in Patients with Advanced-Stage Pulmonary cancer.
Chinchilla-Tábora LM; Montero JC; Corchete LA; González-Morais I; Del Barco Morillo E; Olivares-Hernández A; Rodríguez González M; Sayagués JM; Ludeña MD
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396726
[TBL] [Abstract] [Full Text] [Related]
2. Transcription factor ATMIN facilitates chemoresistance in nasopharyngeal carcinoma.
Fang XL; Li QJ; Lin JY; Huang CL; Huang SY; Tan XR; He SW; Zhu XH; Li JY; Gong S; Qiao H; Li YQ; Liu N; Ma J; Zhao Y; Tang LL
Cell Death Dis; 2024 Feb; 15(2):112. PubMed ID: 38321024
[TBL] [Abstract] [Full Text] [Related]
3. Identification of differentially expressed genes and pathways for risk stratification in HPV-associated cancers governing different anatomical sites.
Kwon EJ; Lee HR; Lee JH; Seo C; Ha M; Roh J; Kim YH; Jang JY
Front Biosci (Landmark Ed); 2022 Jan; 27(1):2. PubMed ID: 35090306
[TBL] [Abstract] [Full Text] [Related]
4. Parallel genome-wide RNAi screens identify lymphocyte-specific protein tyrosine kinase (lck) as a targetable vulnerability of cell proliferation and chemoresistance in nasopharyngeal carcinoma.
Liew K; Yu GQS; Wei Pua LJ; Wong LZ; Tham SY; Hii LW; Lim WM; OuYong BM; Looi CK; Mai CW; Fei-Lei Chung F; Tan LP; Ahmad M; Soo-Beng Khoo A; Leong CO
Cancer Lett; 2021 Apr; 504():81-90. PubMed ID: 33587980
[TBL] [Abstract] [Full Text] [Related]
5. [Comparison of quality of life of hypopharyngeal squamous cell carcinoma patients after laryngeal preservation surgery and total laryngectomy].
Huang ZH; Zhang XW; Ning WJ; Zhao BH; Huang YC; Yan DG; An CM; Zhang ZM; Li ZJ
Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):955-960. PubMed ID: 33256308
[No Abstract] [Full Text] [Related]
6. Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on Thyroid cancer.
Ferrari SM; La Motta C; Sartini S; Baldini E; Materazzi G; Politti U; Ruffilli I; Ulisse S; Miccoli P; Antonelli A; Fallahi P
Mini Rev Med Chem; 2016; 16(2):86-93. PubMed ID: 26471970
[TBL] [Abstract] [Full Text] [Related]
7. Results of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: results of a randomised Phase 2 study.
Richards D; Kocs DM; Spira AI; David McCollum A; Diab S; Hecker LI; Cohn A; Zhan F; Asmar L
Eur J Cancer; 2013 Sep; 49(13):2823-31. PubMed ID: 23747051
[TBL] [Abstract] [Full Text] [Related]
8. Augmentation of T-cell immune responses and signal transduction proteins in oral cancer patients: potential for IL-2-mediated immunotherapy.
Cheriyan VT; Thomas C; Balaram P
J Cancer Res Clin Oncol; 2011 Oct; 137(10):1435-44. PubMed ID: 21809032
[TBL] [Abstract] [Full Text] [Related]
9. Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors.
Montero JC; Seoane S; Ocaña A; Pandiella A
Clin Cancer Res; 2011 Sep; 17(17):5546-52. PubMed ID: 21670084
[TBL] [Abstract] [Full Text] [Related]
